HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Prevention of hepatic encephalopathy].

Abstract
Hepatic encephalopathy (HE) is a frequent complication of cirrhosis which, in addition to producing a great social impact, deteriorates the quality of life of patients and is considered a sign of advanced liver disease and therefore a clinical indication for liver transplant evaluation. Patients who have had episodes of HE have a high risk of recurrence. Thus, after the HE episode resolves, it is recommended: control and prevention of precipitating factors (gastrointestinal bleeding, spontaneous bacterial peritonitis, use of diuretics with caution, avoid nervous system depressant medications), continued administration of non-absorbable disaccharides such as lactulose or lactitol, few or non-absorbable antibiotics such as rifaximin and assess the need for a liver transplant as the presence of a HE episode carries a poor prognosis in cirrhosis.
AuthorsRosa M Morillas, Marga Sala, Ramon Planas
JournalMedicina clinica (Med Clin (Barc)) Vol. 142 Issue 11 Pg. 512-4 (Jun 06 2014) ISSN: 1578-8989 [Electronic] Spain
Vernacular TitleProfilaxis de la encefalopatía hepática.
PMID24480288 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2013 Elsevier España, S.L. All rights reserved.
Chemical References
  • Anti-Bacterial Agents
  • Central Nervous System Depressants
  • Diuretics
  • Rifamycins
  • Sugar Alcohols
  • Lactulose
  • lactitol
  • Rifaximin
Topics
  • Anti-Bacterial Agents (administration & dosage, pharmacokinetics, therapeutic use)
  • Central Nervous System Depressants (adverse effects)
  • Contraindications
  • Diuretics (adverse effects)
  • Gastrointestinal Hemorrhage (etiology)
  • Hepatic Encephalopathy (etiology, prevention & control)
  • Humans
  • Hyperammonemia (etiology, prevention & control)
  • Intestinal Absorption
  • Lactulose (administration & dosage, therapeutic use)
  • Liver Cirrhosis (complications, surgery)
  • Liver Transplantation
  • Meta-Analysis as Topic
  • Peritonitis (complications)
  • Portasystemic Shunt, Surgical (adverse effects)
  • Postoperative Complications (etiology, prevention & control)
  • Recurrence
  • Rifamycins (administration & dosage, pharmacokinetics, therapeutic use)
  • Rifaximin
  • Risk Factors
  • Sugar Alcohols (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: